Beneficient Class A Common Stock (BENF) Stock Forecast & Price Target
Beneficient Class A Common Stock · NASDAQ
$3.13-0.12 (-3.69%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for BENF yet.
12-MONTH PRICE TARGET
$10.00
+219.5% upside
Average analyst target vs $3.13 current
Highest Target$10.00
Average Target$10.00
Lowest Target$10.00
BENF EPS & revenue forecast
EPS · NEXT QUARTER
$-1.58
Range $-1.58 – $-1.58 · 1 analysts · -47% YoY
Next period, 1 analysts expect Beneficient Class A Common Stock to earn $-1.58 a share (range $-1.58 – $-1.58), versus $-2.96 a year earlier. Full-year consensus is $-5.24.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $868.0K, rising to $0 next year.
BENF stock forecast FAQ
What is Beneficient Class A Common Stock's projected EPS for next quarter?+
The consensus estimate is $-1.58 per share (range $-1.58 – $-1.58) across 1 analysts. Full-year EPS is projected at $-5.24, rising to — the following year.
How much revenue is Beneficient Class A Common Stock expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $868.0K, growing to $0 next year.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BENF calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
